Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to -$41.3 million.

  • TriSalus Life Sciences' Net Income towards Common Stockholders fell 118900.69% to -$41.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.3 million, marking a year-over-year decrease of 2292.07%. This contributed to the annual value of -$33.2 million for FY2024, which is 4774.85% up from last year.
  • Per TriSalus Life Sciences' latest filing, its Net Income towards Common Stockholders stood at -$41.3 million for Q3 2025, which was down 118900.69% from -$9.0 million recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Net Income towards Common Stockholders peaked at $2.3 million during Q1 2022, and registered a low of -$41.3 million during Q3 2025.
  • For the 4-year period, TriSalus Life Sciences' Net Income towards Common Stockholders averaged around -$12.5 million, with its median value being -$9.2 million (2023).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 7673.3% in 2023, then crashed by 118900.69% in 2025.
  • Over the past 4 years, TriSalus Life Sciences' Net Income towards Common Stockholders (Quarter) stood at -$25.4 million in 2022, then plummeted by 43.62% to -$36.4 million in 2023, then soared by 70.11% to -$10.9 million in 2024, then plummeted by 278.97% to -$41.3 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$41.3 million for Q3 2025, versus -$9.0 million for Q2 2025 and -$11.1 million for Q1 2025.